To determine how the National Comprehensive Cancer Network (NCCN) guidelines for tamoxifen and aromatase inhibitors (AIs) can be adapted to address the symptom burden for women with breast cancer in the follow up phase of treatment, who are receiving care in the North East of Ireland
No summary available
- Award Date
- 20 October 2016
- Award Value
- €8525
- Principal Investigator
- Ms Elizabeth Summersby
- Host Institution
- University College Dublin
- Scheme
- Project Development Grants